Article info
PDFExtended report
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients
- Correspondence to:
Dr D Gladman
Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, ECW 5–034B, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8; dafna.gladmanutoronto.ca
Citation
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients
Publication history
- Accepted May 20, 2003
- First published January 13, 2004.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Annals of the Rheumatic Diseases